Alerts

A review of the cardiovascular risks associated with the use of the non-steroidal anti-inflammatory drugs (NSAIDs).

Consumers and health professionals are advised that Roche Diagnostic Australia, in consultation with the TGA, has initiated a recall for product correction for its Accu-Chek Spirit Combo insulin pumps.

Recall - potential for particulate contamination